• Affiliate Assistant Professor, Global Health
  • Senior Research Associate, Infectious Diseases Institute, Makerere University

Makerere University
Infectious Diseases Institute Kasangati
Box 22418
Kampala
Uganda

Phone Number: 
+256 754 173 225
Email: 
mujugira@uw.edu
Select from the following:
Biography 

Andrew Mujugira, MBChB, MSc, MPH, PhD, MACE is a Clinical Epidemiologist and Senior Research Scientist at Makerere University Infectious Diseases Institute in Uganda, and Affiliate Assistant Professor in the Department of Global Health at the University of Washington. He has 12 years of experience with HIV pre-exposure prophylaxis (PrEP) efficacy trials, demonstration projects, and implementation science and safety studies. His current research is funded by the National Institutes of Health and industry and focuses on developing methods to build self-efficacy and empowerment, increase antiretroviral adherence and reduce sexual risk behaviors among key populations in Uganda through the use of evidence-based self-controlled HIV prevention tools (HIV self-testing, STI self-sampling, antiretroviral treatment and oral and injectable PrEP).

Education 
  • MBChB (Makerere University)
  • MS (University of London (UK))
Country Affiliations 
Languages 
  • Luganda
  • Runyankore
Health Topics 
  • Epidemiology
  • HIV/AIDS
  • Infectious Diseases
  • Prevention
  • Research
  • Transgender Health
DGH Centers, Programs and Initiatives and Affiliated Organizations 
Publications 

Mujugira A, Nakyanzi A, Kasiita V, Kamusiime B, Nalukwago GK, Nalumansi A, Twesigye CC, Muwonge TR, Baeten JM, Wyatt MA, Haberer JE, Ware NC. HIV Self-Testing and Oral Pre-Exposure Prophylaxis are Empowering for Sex Workers and Their Intimate Partners: A Qualitative Study in Uganda. JIAS. 2021. In press.

Keuroghlian AS, Mujugira A, Mayer KH. Healthcare worker training to improve quality of care for sexual and gender minority people in sub-Saharan Africa: learning from efforts in Uganda. J Int AIDS Soc. 2021 Jul;24 Suppl 3(Suppl 3): e25728. doi: 10.1002/jia2.25728. PMCID: 8242968.

Mujugira A, Baeten JM, Hodges-Mameletzis I, Haberer JE. Lamivudine/Tenofovir Disoproxil Fumarate is an Appropriate PrEP Regimen. Drugs. 2020 Oct 10. doi: 10.1007/s40265-020-01419-4.

Okoboi S, Castelnuovo B, Van Geertruyden JP, Lazarus O, Vu L, Kalibala S, Kamara Y, Ochanda PN, King R, Mujugira A. Cost-Effectiveness of Peer-Delivered HIV Self-Tests for MSM in Uganda. Front Public Health. 2021 Mar 17;9:651325. doi: 10.3389/fpubh.2021.651325.

Nakalega R, Mukiza N, Kiwanuka G, Makanga-Kakumba R, Menge R, Kataike H, Maena J, Akello C, Atuhaire P, Matovu-Kiweewa F, Ndikuno-Kuteesa C, Debem H, Mujugira A. Non-uptake of viral load testing among people receiving HIV treatment in Gomba district, rural Uganda. BMC Infect Dis. 2020 Oct 6;20(1):727.